State Street Corp Replimune Group, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Replimune Group, Inc. stock. As of the latest transaction made, State Street Corp holds 2,340,042 shares of REPL stock, worth $29.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,340,042

Previous 1,157,861 102.1%

Holding current value

$29.3 Million

Previous $10.4 Million 146.12%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $9.56 Million - $13.3 Million	1,182,181 Added 102.1%	2,340,042 $25.6 Million
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $26.7 Million - $50.4 Million	-5,328,835 Reduced 82.15%	1,157,861 $10.4 Million
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $9.45 Million - $12.8 Million	1,375,175 Added 26.9%	6,486,696 $53 Million
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $18.5 Million - $44.3 Million	2,740,876 Added 115.62%	5,111,521 $43.1 Million
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $4.5 Million - $6.25 Million	281,664 Added 13.48%	2,370,645 $40.6 Million
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $12.8 Million - $19.7 Million	-815,373 Reduced 28.07%	2,088,981 $48.5 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $24.9 Million - $41.4 Million	1,424,810 Added 96.3%	2,904,354 $51.3 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $474,572 - $775,032	27,769 Added 1.91%	1,479,544 $40.2 Million
Q3 2022 Nov 15, 2022	SELL	$15.6 - $21.15 $3.12 Million - $4.23 Million	-199,979 Reduced 12.11%	1,451,775 $25.1 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $802,969 - $1.2 Million	-60,283 Reduced 3.52%	1,651,754 $28.9 Million
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $6.99 Million - $13.6 Million	458,420 Added 36.57%	1,712,037 $29.1 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $9.02 Million - $12.2 Million	-354,760 Reduced 22.06%	1,253,617 $34 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $2.18 Million - $2.98 Million	-75,334 Reduced 4.47%	1,608,377 $47.7 Million
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $5.48 Million - $7.56 Million	-192,121 Reduced 10.24%	1,683,711 $64.7 Million
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $9.31 Million - $14 Million	307,945 Added 19.64%	1,875,832 $57.2 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $29.6 Million - $66.4 Million	1,261,306 Added 411.41%	1,567,887 $59.8 Million
Q3 2020 Nov 10, 2020	BUY	$18.85 - $27.0 $418,601 - $599,589	22,207 Added 7.81%	306,581 $7.06 Million
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $692,071 - $1.84 Million	70,909 Added 33.22%	284,374 $7.07 Million
Q1 2020 May 11, 2020	BUY	$8.9 - $19.08 $1.9 Million - $4.07 Million	213,465 New	213,465 $2.13 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $616M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Replimune Group, Inc. Transaction History